Occupational Insecticide Exposure and Risk of Non-Hodgkin Lymphoma: A Pooled Case-Control Study from the InterLymph Consortium - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34270795/
Evidence for the human health effects of pesticides is needed to inform risk assessment. We studied the relationship between occupational insecticide use and risk of non-Hodgkin lymphoma (NHL) by pooling...
Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34267798/
doi: 10.3332/ecancer.2021.1242. 1 Department of Clinical Hematology, Tata Medical Center, 14 Main Arterial Road (EW), Newtown, Kolkata 700160, India. 2 https://orcid.org/0000-0001-9484-5669. 3 Department of Radiation Oncology, Tata Medical Center, 14...
Analysis of clonality in cutaneous B-cell lymphoma and B-cell pseudolymphoma using skin flow cytometry: Comparison of immunophenotyping and gene rearrangement studies - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34263482/
To identify clonal neoplastic cells in skin affected by B-cell lymphoma using skin flow cytometry (FCM) techniques, we investigated light-chain restriction using skin FCM with clonality assessed by polymerase chain...
Flow Cytometric Assessment of Ki-67 Expression in Lymphocytes From Physiologic Lymph Nodes, Lymphoma Cell Populations and Remnant Normal Cell Populations From Lymphomatous Lymph Nodes - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34268346/
Recent literature suggests conventional flow cytometric (FCM) immunophenotyping complemented by Ki-67 FCM assessment as a reliable tool to classify canine lymphomas. Ki-67 expression assessed by FCM is rarely reported in...
Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34225766/
CD19-directed chimeric antigen receptor T cell (CART19) therapy is efficient and approved for relapsed/refractory diffuse large B cell lymphoma (DLBCL). To increase durable antitumor response, we previously designed tandem CART19/20...
-
Naveed Saleh, MD, MS – Skipta Team4yrKey Points • Conclusions/Relevance: “Our data suggest that PD-1 blockade therapy can be active in patients with relapsed/refractory DLBCL after failure of CAR T cell therapy who had PD-L1 expression in Show More